Met Life Investment Management, LLC Ocugen, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 170,456 shares of OCGN stock, worth $95,455. This represents 0.0% of its overall portfolio holdings.
Number of Shares
170,456
Previous 89,508
90.44%
Holding current value
$95,455
Previous $88,000
54.55%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding OCGN
# of Institutions
123Shares Held
68.6MCall Options Held
478KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$10 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.6MShares$9.31 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.59MShares$3.69 Million0.0% of portfolio
-
State Street Corp Boston, MA5.87MShares$3.29 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.37 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $121M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...